Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: March 17, 2016
Pages: 33
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: TCD90C9EF6BEN
Leaflet:

Download PDF Leaflet

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Transition Therapeutics Inc. (Transition) is a biopharmaceutical company that develops medicines for the treatment of CNS disorders, Alzheimer’s disease and diabetes. The company is developing drugs for the treatment of aggression associated with Down syndrome and Alzheimer's disease. It is also developing a metabolic drug candidate for the treatment of type two diabetes and accompanying obesity. Transition is also currently conducting clinical trials on several upcoming drugs for the treatment of various diseases. It partners with various other biopharmaceutical companies to market its products.Transition is headquartered in Toronto, Ontario, Canada.

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deal Details
Partnerships
Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital
Perrigo Amends Development And Commercialization Agreement With Transition Therapeutics For ELND005
Elan Corporation Amends Its Collaboration With Transition Therapeutics
Licensing Agreements
Transition Therapeutics Enters into Licensing Agreement with Eli Lilly for TT701
Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly For TT-601
Transition Therapeutics And Eli Lilly Amend Licensing Agreement
Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly
Equity Offering
Transition Therapeutics Raises USD23 Million in Public Offering of Shares
Transition Therapeutics Raises USD17 Million in Private Placement of Units
Transition Therapeutics Completes Private Placement Of Shares For US$11 Million
Transition Therapeutics Completes Non-Brokered Private Placement Of Shares For US$5 Million
Acquisition
Perrigo To Acquire 7% Stake In Transition Therapeutics For US$15 Million
Transition Therapeutics Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 33

LIST OF TABLES

Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Key Facts, 2015
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Transition Therapeutics Inc., Deals By Therapy Area, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital
Perrigo Amends Development And Commercialization Agreement With Transition Therapeutics For ELND005
Elan Corporation Amends Its Collaboration With Transition Therapeutics
Transition Therapeutics Enters into Licensing Agreement with Eli Lilly for TT701
Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly For TT-601
Transition Therapeutics And Eli Lilly Amend Licensing Agreement
Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly
Transition Therapeutics Raises USD23 Million in Public Offering of Shares
Transition Therapeutics Raises USD17 Million in Private Placement of Units
Transition Therapeutics Completes Private Placement Of Shares For US$11 Million
Transition Therapeutics Completes Non-Brokered Private Placement Of Shares For US$5 Million
Perrigo To Acquire 7% Stake In Transition Therapeutics For US$15 Million
Transition Therapeutics Inc., Key Competitors
Transition Therapeutics Inc., Key Employees
Transition Therapeutics Inc., Subsidiaries 32

LIST OF FIGURES

Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Transition Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Skip to top


Ask Your Question

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: